|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11.08.25 - 12:33
|
Owens & Minor Reports Second Quarter 2025 Financial Results (Business Wire)
|
|
|
Classified Products & Healthcare Services Segment as Discontinued Operations
Continuing Operations, Patient Direct, Showed Solid Performance and GrowthRICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the second quarter ended June 30, 2025. In connection with a likely sale of the Company's Products & Healthcare Services segment, the results herein, unless otherwise noted, reflect the Company's continuing operations which primarily represent what was previously the Patient Direct segment and certain functional operations.
“We are in the final stages of our robust process for the divestiture of the Products & Healthcare Services segment, and, as a result, have classified this segment as discontinued operations. We are looking forward to concluding the sale of the business and working with a buyer who has the vision and greater flexibility to better support our customers and long-term growth,” said Ed Pesicka, Owens & Minor's Chief Executive Officer.
...
|
|
|
|
|
|
|
|
|
04.08.25 - 13:06
|
Owens & Minor Announces Second Quarter 2025 Earnings Release Date and Conference Call (Business Wire)
|
|
|
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the second quarter of 2025 on Monday, August 11, 2025, before trading begins on the New York Stock Exchange.
The Company will host a conference call for investors and analysts at 8:30 a.m. EDT on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917.
All interested stakeholders are encouraged to access the simultaneous live webcast by visiting the Investor Relations page of the Owens & Minor website available at investors.owens-minor.com/events-and-presentations/. A replay of the webcast can be accessed following the presentation at the link provided above.
About Owens & Minor
Owens & Minor, Inc. (NYSE: OMI) is a Fortune 500 global healthcare solutions company providing essential products and services that support care from the hospital to the home. For over 100 years, Owens...
|
|
|
|
|
|
|
28.05.25 - 23:03
|
Jeff Jochims Appointed Executive Chair at Genesee Scientific (Business Wire)
|
|
|
Seasoned Life Sciences Executive to Guide Accelerated GrowthSAN DIEGO--(BUSINESS WIRE)--Genesee Scientific, a leading provider of laboratory essentials for the life sciences industry, is pleased to announce the elevation of Jeff Jochims' role to Executive Chair of the Board. Jochims has served as a member of Genesee's Board of Directors since 2023 and has over 25 years of executive leadership experience in healthcare and life sciences distribution.
“Jeff's deep industry expertise and strategic vision make him an exceptional fit for Genesee Scientific at this critical stage of our growth,” said Dan Monahan, CEO. “His track record in scaling operational excellence and commercial strategy in life sciences distribution will be invaluable as we expand our impact across research and diagnostic markets.”
Jochims has held prominent executive leadership roles at Thermo Fisher Scientific and Owens & Minor and currently serves as Chief Executive Officer at I2Pure. His appointment signals Genesee Scientifi...
|
|
|
|
|
|
|
08.05.25 - 12:36
|
Owens & Minor Reports First Quarter 2025 Financial Results (Business Wire)
|
|
|
Top-Line Growth Led by the Patient Direct Segment
Patient Direct Operating Margin Expanded by 173 Basis Points
Company Reaffirmed 2025 Financial Guidance
Remain Actively Engaged in Potential Sale of Products & Healthcare Services Segment
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the first quarter ended March 31, 2025.
“Across the business we continued to see strong execution and progress towards our near and long-term strategies. Patient Direct delivered mid-single digit top-line growth with strong performance in nearly all therapy categories led by Diabetes and Sleep Supplies. The top-line growth combined with strong operational execution delivered mid-teen expansion in EBITDA for the segment. Our Products & Healthcare Services segment saw top-line growth in our Medical Distribution division, as well as good progress on driving profit improvement initiatives. We remain actively engaged in the sale process of our Products & Healthcare Services s...
|
|
|
|
|
01.05.25 - 12:36
|
Owens & Minor Announces First Quarter 2025 Earnings Release Date and Conference Call (Business Wire)
|
|
|
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the first quarter of 2025 on Thursday, May 8, 2025, before trading begins on the New York Stock Exchange.
The Company will host a conference call for investors and analysts at 8:00 a.m. EDT on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917.
All interested stakeholders are encouraged to access the simultaneous live webcast by visiting the Investor Relations page of the Owens & Minor website available at investors.owens-minor.com/events-and-presentations/. A replay of the webcast can be accessed following the presentation at the link provided above.
About Owens & Minor
Owens & Minor, Inc. (NYSE: OMI) is a Fortune 500 global healthcare solutions company providing essential products and services that support care from the hospital to the home. For over 100 years, Owens & ...
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
